...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith AGM webcast 9/12/2018

https://www.zenithepigenetics.com/upload/media_element/87/02/2018-zenith-agm.pdf.pagespeed.ce.hE_Uq-dI00.pdf

 

There you go....not a ton new to my eyes other than some super responders.

 

bfw

Share
New Message
Please login to post a reply